By InvitationNot Applicable

Celiac Disease in Childhood-Adulthood Transition

Finland400 participantsStarted 2021-11-01

Plain-language summary

Aims of this study are to evaluate adolescents with celiac disease during their transition from pediatrics to adult care, and to develop better healthcare follow-up practices.

Who can participate

Age range13 Years – 19 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * verified celiac disease diagnosis in childhood (\<16 years of age) * age 13-19 years at recruitment * Finnish-speaking Exclusion Criteria: * disease or condition preventing the completing of the study questionnaire Inclusion criteria for controls * no celiac disease diagnosis * age 13-19 years at recruitment * Finnish-speaking

What they're measuring

Adherence to a gluten-free diet

Timeframe: At the onset of the study

Change in adherence to a gluten-free diet

Timeframe: After 1 and 3 years

Transition readiness

Timeframe: At the onset of the study

Change in transition readiness

Timeframe: After 1 and 3 years

Trial details

NCT IDNCT05084937

SponsorTampere University Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-12

View on ClinicalTrials.gov More Celiac Disease trials